Jiangsu Nhwa Pharmaceutical Co., LTD (SHE: 002262)

Market Cap	25.94B
Revenue (ttm)	5.40B
Net Income (ttm)	1.12B
Shares Out	1.02B
EPS (ttm)	1.11
PE Ratio	22.99
Forward PE	19.20
Dividend	0.32 (1.26%)
Ex-Dividend Date	May 15, 2024

Volume	5,311,625
Open	26.18
Previous Close	25.49
Day's Range	25.41 - 26.18
52-Week Range	20.64 - 29.42
Beta	0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Jiangsu Nhwa Pharmaceutical Co., LTD

Jiangsu Nhwa Pharmaceutical Co., LTD engages in research and development, production, marketing, and services related to central nervous system drugs in China and internationally. The company’s products are used for treatment of anesthesia, analgesia, mental and neurological diseases, narcotic, psychiatry, and neurological categories, as well as APIs. It sells its products through hospitals, private hospitals, online pharmacies, and chain pharmacies. The company was founded in 1978 and is headquartered in Xuzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 5,394
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002262

Financial Performance

In 2023, Jiangsu Nhwa Pharmaceutical Co., LTD's revenue was 5.04 billion, an increase of 17.28% compared to the previous year's 4.30 billion. Earnings were 1.04 billion, an increase of 15.12%.